COMPANY
Rio Pharmaceuticals
NIH awards 1
- NIH award 1R41NS105309-01A1 FY2018: $225,000 awarded for that fiscal year; activity R41 (STTR); PI VANBROCKLIN, HENRY F.; recipient as written: RIO PHARMACEUTICALS, INC., SAN FRANCISCO, CA. Astroglial EAAT2 Changes i source ↗